Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carperitide in Congestive Heart Failure
NCT00259038Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2004
- Primary completion
- Feb 2006
- Modality
- Peptides
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Carperitide with Placebo (2 arms). Primary endpoint: Change from baseline in pulmonary capillary wedge pressure at 3 hours. Started Jan 2004; status: completed.
02
Drugs
carperitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00259038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259038.